From October 1, 2023 to December 31, 2023, the company has repurchased 873,000 shares, representing 2.91% for $22.84 million. With this, the company has completed the repurchase of 2,763,000 shares, representing 9.21% for $99.38 million under the buyback announced on March 8, 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
20.1 USD | +0.35% | -1.28% | -30.47% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-30.47% | 601M | |
-17.89% | 8.25B | |
+39.20% | 3.58B | |
-39.11% | 2.46B | |
-8.06% | 2.46B | |
-7.35% | 2.38B | |
-12.61% | 1.81B | |
-19.01% | 1.55B | |
-40.66% | 1.21B | |
+7.56% | 1.11B |
- Stock Market
- Equities
- FLGT Stock
- News Fulgent Genetics, Inc.
- Tranche Update on Fulgent Genetics, Inc.'s Equity Buyback Plan announced on March 8, 2022.